Collectively, these data showed that Bcl-xL splicing inhibition-induced autophagy could promoted apoptosis induction in A172 cells, which is in line with the role of autophagy induced by BH3 mimetics in cancer cells [34, 35]. Here, BCL2L1 is linked to cancer.